Ab­cam finds founder’s op­po­si­tion to Dana­her deal ‘sur­pris­ing,’ say­ing he's sow­ing 'con­fu­sion for share­hold­er­s'

Ab­cam founder Jonathan Mil­ner said he’d vote against Dana­her’s pro­posed buy­out of the bio­phar­ma tools sup­pli­er on Thurs­day, and the UK com­pa­ny ap­peared dumb­found­ed by the tim­ing of his move.

Ab­cam “con­sid­ers it sur­pris­ing that Dr. Mil­ner has tak­en ac­tive steps to op­pose the deal with­out re­view­ing the full de­tails in the Scheme Cir­cu­lar,” the com­pa­ny said in its Thurs­day re­sponse, re­fer­ring to the doc­u­ments it will sub­mit “in the com­ing weeks” that out­line the back­ground of the $5.7 bil­lion trans­ac­tion, the bid­ding process in­volved and the ad­vice of its board and bankers.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER